These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9853977)

  • 1. Relative biologic availability and pharmacokinetics of albuterol preparations in healthy Chinese.
    Yuan Y; Li K; Zhao F
    Ther Drug Monit; 1998 Dec; 20(6):624-7. PubMed ID: 9853977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative bioavailability of a controlled-release albuterol formulation for twice-daily use.
    Sykes RS; Reese ME; Meyer MC; Chubb JM
    Biopharm Drug Dispos; 1988; 9(6):551-6. PubMed ID: 3228576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative steady state bioavailability of conventional and controlled-release formulations of albuterol.
    Powell ML; Weisberger M; Dowdy Y; Gural R; Symchowicz S; Patrick JE
    Biopharm Drug Dispos; 1987; 8(5):461-8. PubMed ID: 3663882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
    Hussey EK; Donn KH; Powell JR
    Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease.
    Maesen FP; Smeets JJ
    Eur J Clin Pharmacol; 1986; 31(4):431-6. PubMed ID: 3816923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuterol extended-release products: effect of food on the pharmacokinetics of single oral doses of Volmax and Proventil Repetabs in healthy male volunteers.
    Hussey EK; Donn KH; Powell JR; Lahey AP; Pakes GE
    J Clin Pharmacol; 1991 Jun; 31(6):561-4. PubMed ID: 1880222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone.
    Mandema JW; Kaiko RF; Oshlack B; Reder RF; Stanski DR
    Br J Clin Pharmacol; 1996 Dec; 42(6):747-56. PubMed ID: 8971431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the steady-state pharmacokinetics of immediate-release and controlled-release diltiazem tablets.
    Leeuwenkamp OR; Visscher HW; Mensink CK; Jonkman JH
    Eur J Clin Pharmacol; 1994; 46(3):243-7. PubMed ID: 8070505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.
    Sista S; Lai JC; Eradiri O; Albert KS
    J Clin Pharmacol; 2003 Oct; 43(10):1149-57. PubMed ID: 14517197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.
    Adjei A; Teuscher NS; Kupper RJ; Chang WW; Greenhill L; Newcorn JH; Connor DF; Wigal S
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):570-8. PubMed ID: 25514542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared With Immediate-release Methylphenidate Chewable Tablet.
    Abbas R; Palumbo D; Walters F; Belden H; Berry SA
    Clin Ther; 2016 May; 38(5):1151-7. PubMed ID: 27021606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
    Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
    J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects.
    Zannikos PN; Smit JW; Stahlberg HJ; Wenge B; Hillewaert VM; Etropolski MS
    J Opioid Manag; 2013; 9(4):291-300. PubMed ID: 24353023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.